KRAS and neoplasm: Furthermore, tumours without KRAS gene mutation show overexpression of ALDOB and CPS1 and downregulation of PGAM4 genes, which are involved in metabolic pathways such as biosynthesis of amino acids, gluconeogenesis, glycolysis and carbon metabolism (Table S5B).